|
European Group on Life Sciences *
Over the past decades the life sciences have made tremendous strides,
with major potential benefits for human health, the environment, and European industry. The almost
complete sequencing of the human genome is an example of this. At the same time, applications of the
new knowledge raise ethical and safety concerns among the public and policy-makers that must be addressed.
The European Group on Life Sciences
(EGLS) was established in April 2000 for a four years mandate (2000-2004)
by the Research Commissioner Philippe Busquin to meet his need for
high-level advice on the life sciences and technologies. One of
the group's tasks was to inform the Research Commissioner on the
current situation in this field and on imminent or foreseeable developments.
Another objective was to contribute to the organisation and animation
of a Life Sciences Discussion Platform, enabling scientists to engage
in a debate with the various 'stakeholders' interested in the beneficial
application and dissemination of the new knowledge.
* Until 2001 the Group acted under
the name "Life Sciences High-level Group" (LSHLG)
Brochure
Brochure
- European Group on Life Sciences (3rd edition, Dec. 2004, with
new text "Conclusions of the EGLS on the future of life sciences
research") (
642 KB)
CORDIS News: Life sciences group concludes term with list of challenges for the future
(13 January 2005)]
|
* 
